Mysteries of renal autoregulation

Hypertension

Volumn 53, Issue 2, 2009, Pages 299-306

  Inscho, Edward W ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; PURINERGIC P2 RECEPTOR;

ARTERIOLE; ARTICLE; AUTOREGULATION; BLOOD VESSEL REACTIVITY; DIABETES MELLITUS; FEEDBACK SYSTEM; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; MICROVASCULARIZATION; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; VASOCONSTRICTION; ANIMAL; DISEASE MODEL; GLOMERULUS; HEMODYNAMICS; HOMEOSTASIS; KIDNEY; PATHOPHYSIOLOGY; PHYSIOLOGY; VASCULARIZATION;

ANIMALS; DISEASE MODELS, ANIMAL; HEMODYNAMICS; HOMEOSTASIS; HUMANS; HYPERTENSION; KIDNEY; KIDNEY GLOMERULUS; SIGNAL TRANSDUCTION;

EID: 59849121081     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.108.119982     Document Type: Article

References (70)

1. Loutzenhiser R, Griffin K, Williamson G, Bidani A. Renal autoregulation: New perspectives regarding the protective and regulatory roles of the underlying mechanisms. Am J Physiol Regul Integr Comp Physiol. 2006; 290: R1153-R1167.
2. Griffin KA, Bidani A. Hypertensive renal damage: Insights from animal models and clinical relevance. Curr Hypertens Rep. 2004; 145-153.
3. Schnermann J, Levine DZ. Paracrine factors in tubuloglomerular feedback: Adenosine, ATP and nitric oxide. Ann Rev Physiol. 2003; 65: 501-529.
4. Navar LG, Inscho EW, Majid DSA, Imig JD, Harrison-Bernard LM, Mitchell KD. Paracrine regulation of the renal microcirculation. Physiol Rev. 1996; 76: 425-536.
5. Bell PD, Lapointe JY, Peti-Peterdi J. Macula densa cell signaling. Ann Rev Physiol. 2003; 65: 481-500.
6. Just A, Arendshorst WJ. Dynamics and contribution of mechanisms mediating renal blood flow autoregulation. Am J Physiol Regul Integr Comp Physiol. 2003; 285: R619-R631.
7. Just A. Mechanisms of renal blood flow autoregulation: Dynamics and contributions. Am J Physiol Regul Integr Comp Physiol. 2007; 292: R1-R17.
8. Inscho EW. P2 receptors in the regulation of renal microvascular function. Am J Physiol Renal Physiol. 2001; 280: F927-F944.
9. Guan Z, Osmond DA, Inscho EW. P2X receptors as regulators of the renal microvasculature. Trends Pharmacol Sci. 2007; 28: 646-652.
10. Bell PD, Lapointe J-Y, Sabirov R, Hayashi S, Peti-Peterdi J, Manabe K, Kovacs G, Okada Y. Macula densa cell signaling involves ATP release through a maxi anion channel. Proc Natl Acad Sci U S A. 2003; 100: 4322-4327.
11. Peti-Peterdi J. Calcium wave of tubuloglomerular feedback. Am J Physiol Renal Physiol. 2006; 291: F473-F480.
12. Casellas D, Carmines PK. Control of the renal microcirculation: Cellular and integrative perspectives. Curr Opin Nephrol Hypertension. 1996; 5: 57-63.
13. Hayashi K, Epstein M, Loutzenhiser R. Pressure-induced vasoconstriction of renal microvessels in normotensive and hypertensive rats: Studies in the isolated perfused hydronephrotic kidney. Circ Res. 1989; 65: 1475-1484.
14. White SM, Imig JD, Inscho EW. Calcium signaling pathways utilized by P2X receptors in preglomerular vascular smooth muscle cells. Am J Physiol Renal Physiol. 2001; 280: F1054-F1061.
15. North RA. Molecular physiology of P2X receptors. Physiol Rev. 2002; 82: 1013-1067.
16. Fredholm BB, Abbracchio MP, Burnstock G, Daly JW, Harden TK, Jacobson KA, Leff P, Williams M. Nomenclature and classification of purinoceptors. Pharmacol Rev. 1994; 46: 143-156.
17. Olsson RA. Adenosine receptors in the cardiovascular system. Drug Dev Res. 1996; 39: 301-307.
18. Martinka P, Lai EY, Fahling M, Jankowski V, Jankowski J, Schubert R, Gaestel M, Persson AEG, Persson PB, Patzak A. Adenosine increases calcium sensitivity via receptor-independent activation of the p38/MK2 pathway in mesenteric arteries. Acta Physiol. 2008; 193: 37-46.
19. Inscho EW, Cook AK, Imig JD, Vial C, Evans RJ. Physiological role for P2X1 receptors in renal microvascular autoregulatory behavior. J Clin Invest. 2003; 112: 1895-1905.
20. Randriamboavonjy V, Busse R, Fleming I. 20-HETE-induced contraction of small coronary arteries depends on the activation of rho-kinase. Hypertension. 2003; 41: 801-806.
21. Kaley G. Regulation of vascular tone - role of 20-HETE in the modulation of myogenic reactivity. Circ Res. 2000; 87: 4-5.
22. Imig JD, Falck JR, Gebremedhin D, Harder DR, Roman RJ. Elevated renovascular tone in young spontaneously hypertensive rats: Role of cytochrome P-450. Hypertension. 1993; 22: 357-364.
23. Frisbee JC, Roman RJ, Krishna UM, Falck JR, Lombard JH. 20-HETE modulates myogenic response of skeletal muscle resistance arteries from hypertensive Dahl-SS rats. Am J Physiol Heart Circ Physiol. 2001; 280: H1066-H1074.
24. Zhao XY, Inscho EW, Bondlela M, Falck JR, Imig JD. The CYP450 hydroxylase pathway contributes to P2X receptor-mediated afferent arteriolar vasoconstriction. Am J Physiol Heart Circ Physiol. 2001; 281: H2089-H2096.
25. Zhao X, Falck JR, Gopal VR, Inscho EW, Imig JD. P2X receptorstimulated calcium responses in preglomerular vascular smooth muscle cells involves 20-hydroxyeicosatetraenoic acid. J Pharmacol Exp Ther. 2004; 311: 1211-1217.
26. Gebremedhin D, Lange AR, Lowry TF, Taheri MR, Birks EK, Hudetz AG, Narayanan J, Falck JR, Okamoto H, Roman RJ, Nithipatikom K, Campbell WB, Harder DR. Production of 20-HETE and its role in autoregulation of cerebral blood flow. Circ Res. 2000; 87: 60-65.
27. Schubert R, Kalentchuk VU, Krien U. Rho kinase inhibition partly weakens myogenic reactivity in rat small arteries by changing calcium sensitivity. Am J Physiol Heart Circ Physiol. 2002; 283: H2288-H2295.
28. Ito S, Kume H, Honjo H, Katoh H, Kodama I, Yamaki K, Hayashi H. Possible involvement of Rho kinase in Ca2- sensitization and mobilization by MCh in tracheal smooth muscle. Am J Physiol Lung Cell Mol Physiol. 2001; 280: L1218-L1224.
29. Nakamura A, Hayashi K, Ozawa Y, Fujiwara K, Okubo K, Kanda T, Wakino S, Saruta T. Vessel- And vasoconstrictor-dependent role of rho/rho-kinase in renal microvascular tone. J Vasc Res. 2003; 40: 244-251.
30. Cavarape A, Endlich N, Assaloni R, Bartoli E, Steinhausen M, Parekh N, Endlich K. Rho-kinase inhibition blunts renal vasoconstriction induced by distinct signaling pathways in vivo. J Am Soc Nephrol. 2003; 14: 37-45.
31. Grygorczyk R, Guyot A. Osmotic swelling-induced ATP release: A new role for tyrosine and Rho-kinases? J Physiol (Lond). 2001; 532: 582.
32. Wang D, Chabrashvili T, Wilcox CS. Enhanced contractility of renal afferent arterioles from angiotensin-infused rabbits: Roles of oxidative stress, thromboxane prostanoid receptors, and endothelium. Circ Res. 2004; 94: 1436-1442.
33. Sharma K, Cook A, Smith M, Valancius C, Inscho EW. TGF- impairs renal autoregulation via generation of ROS. Am J Physiol Renal Fluid Electrolyte Physiol. 2005; 288: F1069-F1077.
34. Wilcox CS. Redox regulation of the afferent arteriole and tubuloglomerular feedback. Acta Physiol Scand. 2003; 179: 217-223.
35. Inscho EW, Carmines PK, Cook AK, Navar LG. Afferent arteriolar responsiveness to altered perfusion pressure in renal hypertension. Hypertension. 1990; 15: 748-752.
36. Inscho EW, Imig JD, Deichmann PC, Cook AK. Candesartan-Cilexetil protects against loss of autoregulatory efficiency in angiotensin II infused rats. J Am Soc Nephrol. 1999; 10(suppl 11): S178-S183.
37. Inscho EW, Cook AK, Murzynowski J, Imig JD. Elevated arterial pressure impairs autoregulation independently of AT1 receptors. J Hypertens. 2004; 22: 811-818.
38. Jernigan NL, Drummond HA. Myogenic vasoconstriction in mouse renal interlobar arteries: Role of endogenous beta and {gamma}ENaC. Am J Physiol Renal Physiol. 2006; 291: F1184-F1191.
39. Wang X, Takeya K, Aaronson PI, Loutzenhiser K, Loutzenhiser R. Effects of amiloride, benzamil, and alterations in extracellular Na- on the rat afferent arteriole and its myogenic response. Am J Physiol Renal Physiol. 2008; 295: F272-F282.
40. Balasubramanian L, Ahmed A, Lo CM, Sham JSK, Yip KP. Integrinmediated mechanotransduction in renal vascular smooth muscle cells: Activation of calcium sparks. Am J Physiol Regul Integr Comp Physiol. 2007; 293: R1586-R1594.
41. Davis MJ, Wu X, Nurkiewicz TR, Kawasaki J, Davis GE, Hill MA, Meininger GA. Integrins and mechanotransduction of the vascular myogenic response. Am J Physiol Heart Circ Physiol. 2001; 280: H1427-H1433.
42. Martinez-Lemus LA, Wu X, Wilson E, Hill MA, Davis GE, Davis MJ, Meininger GA. Integrins as unique receptors for vascular control. J Vasc Res. 2003; 40: 211-233.
43. Toma I, Bansal E, Meer EJ, Kang JJ, Vargas SL, Peti-Peterdi J. Connexin 40 and ATP-dependent intercellular calcium wave in renal glomerular endothelial cells. Am J Physiol Regul Integr Comp Physiol. 2008; 294: R1769-R1776.
44. Inscho EW, Cook AK, Webb RC. Rho-kinase inhibition reduces pressuremediated autoregullatory adjustments in afferent arteriolar diameter. Hypertension. 2003; 42: 388. Abstract.
45. Boudreault F, Grygorczyk R. Cell swelling-induced ATP release and gadolinium-sensitive channels. Am J Physiol Cell Physiol. 2002; 282: C219-C226.
46. Komlosi P, Peti-Peterdi J, Fuson AL, Fintha A, Rosivall L, Bell PD. Macula densa basolateral ATP release is regulated by luminal [NaCl] and dietary salt intake. Am J Physiol Renal Physiol. 2004; 286: F1054-F1058.
47. Schwiebert EM. ATP release mechanisms, ATP receptors and purinergic signalling along the nephron. Clin Exp Pharmacol Physiol. 2001; 28: 340-350.
48. Sprague RS, Ellsworth ML, Stephenson AH, Lonigro AJ. Participation of cAMP in a signal-transduction pathway relating erythrocyte deformation to ATP release. Am J Physiol Cell Physiol. 2001; 281: C1158-C1164.
49. Schwiebert EM, Kishore BK. Extracellular nucleotide signaling along the renal epithelium. Am J Physiol Renal Physiol. 2001; 280: F945-F963.
50. Nishiyama A, Majid DSA, Walker M, III, Miyatake A, Navar LG. Renal interstitial ATP responses to changes in arterial pressure during alterations in tubuloglomerular feedback activity. Hypertension. 2001; 37: 753-759.
51. Nishiyama A, Majid DSA, Taher KA, Miyatake A, Navar LG. Relation between renal interstitial ATP concentrations and autoregulationmediated changes in renal vascular resistance. Circ Res. 2000; 86: 656-662.
52. Inscho EW, Ohishi K, Navar LG. Effects of ATP on pre- And postglomerular juxtamedullary microvasculature. Am J Physiol Renal, Fluid Electrolyte Physiol. 1992; 263: F886-F893.
53. Perez-Reyes E, Lee JH, Cribbs LL. Molecular characterization of two members of the T-type calcium channel family. Ann N Y Acad Sci. 1999; 868: 131-143.
54. Liu R, Bell PD, Peti-Peterdi J, Kovacs G, Johansson A, Persson AEG. Purinergic receptor signaling at the basolateral membrane of macula densa cells. J Am Soc Nephrol. 2002; 13: 1145-1151.
55. Wagner C, De Wit C, Gerl M, Kurtz A, Hocherl K. Increased expression of cyclooxygenase 2 contributes to aberrant renin production in connexin 40-deficient kidneys. Am J Physiol Regul Integr Comp Physiol. 2007; 293: R1781-R1786.
56. Wagner C, De Wit C, Kurtz L, Grunberger C, Kurtz A, Schweda F. Connexin40 is essential for the pressure control of renin synthesis and secretion. Circ Res. 2007; 100: 556-563.
57. Kurtz L, Schweda F, De Wit C, Kriz W, Witzgall R, Warth R, Sauter A, Kurtz A, Wagner C. Lack of Connexin 40 causes displacement of reninproducing cells from afferent arterioles to the extraglomerular mesangium. J Am Soc Nephrol. 2007: 1103-1111.
58. Fitzgerald SM, Evans RG, Bergström G, Anderson WP. Renal hemodynamic responses to intrarenal infusion of ligands for the putative angiotensin IV receptor in anesthetized rats. J Cardiovasc Pharmacol. 1999; 34: 206-211.
59. Imig JD, Inscho EW. Adaptations of the renal microcirculation to hypertension. Microcirculation. 2002; 9: 315-328.
60. Persson PB. Renal blood flow autoregulation in blood pressure control. Curr Opin Nephrol Hypertension. 2002; 11: 67-72.
61. Racasan S, Joles JA, Boer P, Koomans HA, Braam B. NO dependency of RBF and autoregulation in the spontaneously hypertensive rat. Am J Physiol Renal Physiol. 2003; 285: F105-F112.
62. Arendshorst WJ. Autoregulation of renal blood flow in spontaneously hypertensive rats. Circ Res. 1979; 44: 344-349.
63. Arendshorst WJ, Beierwaltes WH. Renal and nephron hemodynamics in spontaneously hypertensive rats. Am J Physiol Renal Physiol. 1979; 236: F246-F251.
64. Welch WJ. Adenosine type 1 receptor antagonists in fluid retaining disorders. Expert Opin Investig Drugs. 2002; 11: 1553-1562.
65. Vonend O, Turner CM, Chan CM, Loesch A, Dell'Anna GC, Srai KS, Burnstock G, Unwin RJ. Glomerular expression of the ATP-sensitive P2X receptor in diabetic and hypertensive rat models. Kidney Int. 2004; 66: 157-166.
66. Graciano ML, Nishiyama A, Jackson K, Seth DM, Ortiz RM, Prieto- Carrasquero MC, Kobori H, Navar LG. Purinergic receptors contribute to early mesangial cell transformation and renal vessel hypertrophy during angiotensin II-induced hypertension. Am J Physiol Renal Physiol. 2007; 294: F161-F169.
67. Liu R, Persson AEG. Effects of nitric oxide on P2Y receptor resensitization in spontaneously hypertensive rat mesangial cells. J Hypertens. 2002; 20: 1835-1842.
68. Zhao X, Cook AK, Field M, Edwards B, Zhang S, Zhang Z, Pollock JS, Imig JD, Inscho EW. Impaired Ca2- signaling attenuates P2X receptormediated vasoconstriction of afferent arterioles in angiotensin II hypertension. Hypertension. 2005; 46: 562-568.
69. Wang CT, Chin SY, Navar LG. Impairment of pressure-natriuresis and renal autoregulation in ANG II-infused hypertensive rats. Am J Physiol Renal Physiol. 2000; 279: F319-F325.
70. Welch WJ, Baumgartl H, Lubbers D, Wilcox CS. Renal oxygenation defects in the spontaneously hypertensive rat: Role of AT1 receptors. Kidney Int. 2003; 63: 202-208.